Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Mesothelin family proteins and diagnosis of mesothelioma: analytical evaluation of an automated immunoassay and preliminary clinical results.

Di Serio F, Fontana A, Loizzi M, Capotorto G, Maggiolini P, Mera E, Bisceglia L, Molinini R.

Clin Chem Lab Med. 2007;45(5):634-8.

PMID:
17484626
2.

Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein.

Creaney J, Robinson BW.

Hematol Oncol Clin North Am. 2005 Dec;19(6):1025-40, v. Review.

PMID:
16325121
3.

Diagnostic value of soluble mesothelin-related peptides for malignant mesothelioma: a meta-analysis.

Luo L, Shi HZ, Liang QL, Jiang J, Qin SM, Deng JM.

Respir Med. 2010 Jan;104(1):149-56. doi: 10.1016/j.rmed.2009.05.017. Epub 2009 Nov 30. Review.

4.

Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis.

Hollevoet K, Reitsma JB, Creaney J, Grigoriu BD, Robinson BW, Scherpereel A, Cristaudo A, Pass HI, Nackaerts K, Rodríguez Portal JA, Schneider J, Muley T, Di Serio F, Baas P, Tomasetti M, Rai AJ, van Meerbeeck JP.

J Clin Oncol. 2012 May 1;30(13):1541-9. doi: 10.1200/JCO.2011.39.6671. Epub 2012 Mar 12. Review.

5.

Serum and pleural fluid biomarkers for mesothelioma.

Creaney J, Robinson BW.

Curr Opin Pulm Med. 2009 Jul;15(4):366-70. doi: 10.1097/MCP.0b013e32832b98eb. Review.

PMID:
19417672
6.

Molecular tumor markers for asbestos-related mesothelioma: serum diagnostic markers.

Maeda M, Hino O.

Pathol Int. 2006 Nov;56(11):649-54. Review.

PMID:
17040286
7.

Blood tests for asbestos-related mesothelioma.

Maeda M, Hino O.

Oncology. 2006;71(1-2):26-31. Epub 2007 Mar 5. Review.

PMID:
17344668
8.

Biomarkers for mesothelioma.

Scherpereel A, Lee YC.

Curr Opin Pulm Med. 2007 Jul;13(4):339-443. Review.

PMID:
17534183
9.

[New diagnostic markers for malignant pleural mesothelioma].

Grigoriu BD, Grégoire M, Chahine B, Scherpereel A.

Bull Cancer. 2008 Feb;95(2):177-84. doi: 10.1684/bdc.2008.0576. Review. French.

10.

Comparison of mesothelin and fibulin-3 in pleural fluid and serum as markers in malignant mesothelioma.

Creaney J, Dick IM, Robinson BW.

Curr Opin Pulm Med. 2015 Jul;21(4):352-6. doi: 10.1097/MCP.0000000000000167. Review.

PMID:
26016578
11.

Clinical utility of diagnostic markers for malignant pleural mesothelioma.

Grigoriu BD, Grigoriu C, Chahine B, Gey T, Scherpereel A.

Monaldi Arch Chest Dis. 2009 Mar;71(1):31-8. Review. Erratum in: Monaldi Arch Chest Dis. 2009 Jun;71(2):88.

PMID:
19522163
12.

Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma.

Pantazopoulos I, Boura P, Xanthos T, Syrigos K.

Eur Respir J. 2013 Mar;41(3):706-15. doi: 10.1183/09031936.00226111. Epub 2012 Jul 26. Review.

13.

Discovery of new biomarkers for malignant mesothelioma.

Creaney J, Dick IM, Robinson BW.

Curr Pulmonol Rep. 2015;4(1):15-21. Review.

Supplemental Content

Support Center